Shushan Hovsepyan: Where does immunotherapy fit in the treatment landscape of sarcoma?

Shushan Hovsepyan shared on LinkedIn:

“Where does immunotherapy fit in the treatment landscape of sarcoma?

To learn more about this fascinating topic, watch my latest 5-minute Sarcoma Talk on OncoDaily.

I had the privilege of speaking with one of the key experts in sarcoma Dr. Sandra D’Angelo from Memorial Sloan Kettering Cancer Center. She discussed the role of different immunotherapeutic agents in soft tissue sarcomas, specifically about the Afami-cel, which just received the FDA accelerated approval.

Take a moment to watch and share your thoughts!”

Source: Shushan Hovsepyan/LinkedIn

Shushan Hovsepyan is a pediatric oncologist and adjunct assistant professor at the Yerevan State Medical University. Currently, she is the Editor-in-Chief of OncoDaily Medical Journal.

She completed her clinical fellowship at the National Institute of Cancer in Milan, Italy and at the St. Anna Children’s Research Hospital in Austria Furthermore, she held a research fellowship position at the European Organisation for Research and Treatment of Cancer in Brussels, Belgium. She is a former co-chair of the SIOP Global Health Network Education and Training Working Group.

Find other episodes of 5-minute Sarcoma Talk on OncoDaily.